Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcelo Freire

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Contemporary Clinical Trials Communications|December 17, 2025
Design and rationale for the VICTRIVA study: A randomized, double-blind, phase 3b study of vedolizumab in combination with upadacitinib in Crohn's diseaseSilvio Danese, Bruce E Sands, Brian G Feagan, et al.
Inflammatory Bowel Diseases|September 16, 2024
Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative ColitisDavid T Rubin, Olga Kubassova, Christopher R Weber, et al.
United European Gastroenterology Journal|July 2, 2026
Global Roll-Out and Continued Multi-Site Validation of the Artificial Intelligence Histology Instrument for Qualitative Assessment of Histopathology in Ulcerative ColitisLaurent Peyrin-Biroulet, Olga Kubassova, Jon Himoff, et al.
BMJ Open Gastroenterology|February 20, 2026
Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn's disease: rationale, design and protocol for the randomised controlled VECTORS trialVipul Jairath, Sudheer K Vuyyuru, Guangyong Zou, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
Machine Learning Analysis of Post-Acute COVID Symptoms Identifies Distinct Clusters, Severity Groups, and TrajectoriesBeverly Peng, Thomas Dalhuisen, Aidan Rogers, et al.
Science Advances|August 14, 2021
Coral microbiome manipulation elicits metabolic and genetic restructuring to mitigate heat stress and evade mortalityErika P Santoro, Ricardo M Borges, Josh L Espinoza, et al.
BMJ Open Gastroenterology|February 9, 2024
Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trialVipul Jairath, Guangyong Zou, Zhongya Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2025
Inflammasome targeting for periodontitis prevention is sex dependentTomaz Alves, Karen V Swanson, Mustafa S Girnary, et al.
Nature Immunology|September 4, 2023
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)Amy D Proal, Michael B VanElzakker, Soo Aleman, et al.
The Lancet. Infectious Diseases|February 13, 2025
Targeting the SARS-CoV-2 reservoir in long COVIDAmy D Proal, Soo Aleman, Morgane Bomsel, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Contemporary Clinical Trials Communications|December 17, 2025
Design and rationale for the VICTRIVA study: A randomized, double-blind, phase 3b study of vedolizumab in combination with upadacitinib in Crohn's diseaseSilvio Danese, Bruce E Sands, Brian G Feagan, et al.
Inflammatory Bowel Diseases|September 16, 2024
Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative ColitisDavid T Rubin, Olga Kubassova, Christopher R Weber, et al.
United European Gastroenterology Journal|July 2, 2026
Global Roll-Out and Continued Multi-Site Validation of the Artificial Intelligence Histology Instrument for Qualitative Assessment of Histopathology in Ulcerative ColitisLaurent Peyrin-Biroulet, Olga Kubassova, Jon Himoff, et al.
BMJ Open Gastroenterology|February 20, 2026
Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn's disease: rationale, design and protocol for the randomised controlled VECTORS trialVipul Jairath, Sudheer K Vuyyuru, Guangyong Zou, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
Machine Learning Analysis of Post-Acute COVID Symptoms Identifies Distinct Clusters, Severity Groups, and TrajectoriesBeverly Peng, Thomas Dalhuisen, Aidan Rogers, et al.
Science Advances|August 14, 2021
Coral microbiome manipulation elicits metabolic and genetic restructuring to mitigate heat stress and evade mortalityErika P Santoro, Ricardo M Borges, Josh L Espinoza, et al.
BMJ Open Gastroenterology|February 9, 2024
Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trialVipul Jairath, Guangyong Zou, Zhongya Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2025
Inflammasome targeting for periodontitis prevention is sex dependentTomaz Alves, Karen V Swanson, Mustafa S Girnary, et al.
Nature Immunology|September 4, 2023
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)Amy D Proal, Michael B VanElzakker, Soo Aleman, et al.
The Lancet. Infectious Diseases|February 13, 2025
Targeting the SARS-CoV-2 reservoir in long COVIDAmy D Proal, Soo Aleman, Morgane Bomsel, et al.
Pageof 6